Literature DB >> 22074579

Dopamine: the forgotten felon in type 2 diabetes.

Sanjay Kalra1, Bharti Kalra, Navneet Agrawal, Satish Kumar.   

Abstract

This paper reviews recent patents and development related to bromocriptine and other dopaminergic agents, being used or suggested for use in the management of diabetes. The article discusses the contribution of dopaminergic pathways to glucose, energy and weight homeostasis. The mechanism of action of bromocriptine, its pharmacological properties, efficacy, safety and tolerability are assessed. The article also covers recent patents which may be utilized to improve the efficiency and tolerability of dopamine-based therapy in diabetes mellitus.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22074579     DOI： 10.2174/187221411794351842

Source DB:  PubMed          Journal:  Recent Pat Endocr Metab Immune Drug Discov        ISSN： 1872-2148


  8 in total

1.  Role of Macrophage Dopamine Receptors in Mediating Cytokine Production: Implications for Neuroinflammation in the Context of HIV-Associated Neurocognitive Disorders.

Authors:  R A Nolan; R Muir; K Runner; E K Haddad; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2018-12-05       Impact factor: 4.147

2.  Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion.

Authors:  Despoina Aslanoglou; Emily W George; Zachary Freyberg
Journal:  J Vis Exp       Date:  2018-05-10       Impact factor: 1.355

3.  Bromocriptine in type 2 diabetes mellitus.

Authors:  C Shivaprasad; Sanjay Kalra
Journal:  Indian J Endocrinol Metab       Date:  2011-07

4.  Adrenergic India: Managing its diabetes.

Authors:  Sanjay Kalra; Vageesh Ayyar; Ambika Gopalakrishnan Unnikrishnan
Journal:  Indian J Endocrinol Metab       Date:  2011-07

5.  Intrinsic and Antipsychotic Drug-Induced Metabolic Dysfunction in Schizophrenia.

Authors:  Zachary Freyberg; Despoina Aslanoglou; Ripal Shah; Jacob S Ballon
Journal:  Front Neurosci       Date:  2017-07-28       Impact factor: 4.677

6.  The dirty dozen of diabetes.

Authors:  Sanjay Kalra; Rajeev Chawla; S V Madhu
Journal:  Indian J Endocrinol Metab       Date:  2013-05

7.  Development of a Rapid Insulin Assay by Homogenous Time-Resolved Fluorescence.

Authors:  Zachary J Farino; Travis J Morgenstern; Julie Vallaghe; Nathalie Gregor; Prashant Donthamsetti; Paul E Harris; Nicolas Pierre; Robin Freyberg; Fabienne Charrier-Savournin; Jonathan A Javitch; Zachary Freyberg
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

Review 8.  Adenosine monophosphate-activated protein kinase-based classification of diabetes pharmacotherapy.

Authors:  D Dutta; S Kalra; M Sharma
Journal:  J Postgrad Med       Date:  2017 Apr-Jun       Impact factor: 1.476
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.